Nima Ghalehsari, MD
Nima Ghalehsari, MD
Specialty: Blood and Marrow Transplant and Cellular Immunotherapy
Program: Blood and Marrow Transplant and Cellular Immunotherapy
Language(s): English
-
Overview
Cancer Focus:
Hodgkin Lymphoma, Non-Hodgkin LymphomaDr. Ghalehsari earned his MD degree from St. George’s University School of Medicine, Grenada, West Indies. He completed an Internal Medicine Residency followed by a Hematology and Medical Oncology Fellowship at New York-Presbyterian Brooklyn Methodist Hospital/Weill Cornell Medicine. Dr. Ghalehsari most recently completed a Bone Marrow Transplantation/ Cellular Therapy Fellowship at Stanford University School of Medicine, California.
Dr. Ghalehsari’s clinical interests include cell therapy, particularly CAR-T therapy in lymphoma and solid-tumor malignancies, as well as bone marrow transplantation in hematologic cancers. His research portfolio spans outcomes of CAR T in older patients, radiomics and metabolic tumor volume as predictors of efficacy, and mechanisms of relapse including antigen loss. He has presented his work nationally, which includes oral presentations at the American Society of Hematology. He has authored peer-reviewed publications on transplant outcomes, health disparities in multiple myeloma, and immune-based therapies. In addition to his clinical and research pursuits, Dr. Ghalehsari has demonstrated strong leadership and mentorship throughout his training, serving as Chief Medical Resident at Weill Cornell and actively contributing to national initiatives on diversity and access in cellular therapy.
-
Publications
- Ghalehsari N, Pandey M, Auletta JJ, Beaver E, Davies SM, Espinoza-Gutarra MR, Fraint E, Holter-Chakrabarty J, Howard D, Knutson J, Maloney A, Ginocchio MAP, Ramos KN, Shah R, Hall AG, Gomez-Arteaga A. Physician Advocacy for Hematopoietic Cell Transplantation and Cell Therapy: Overcoming Challenges to Reduce Disparities and Improve Outcomes for Patients. Transplant Cell Ther. 2025 Sep. Pubmedid: 41016708.
- Ghalehsari N, Zahid S, Main O, Usta S, Patresan J, Amin A, Ashraf F, Mazloom A, Huang A, Goldfinger M, Monge J. Exploring health disparities in diagnosing multiple myeloma. Expert Rev Hematol. 2024 Oct.17(10):749-753. Pubmedid: 39104264.
- Ghalehsari N, Castillo Tokumori F, Chen Z, Liu M, Mayer SA, Zeinah GA, Shore TB, Ritchie EK, Silver RT, Scandura JM, Roboz GJ, van Besien K, Gomez-Arteaga A. Transplant Outcomes in Myelofibrosis: Impact of Donor Type (Cord Blood Grafts Supported by CD34+ selected Cells [Haplo-Cord] Versus Matched Donors). Transplant Cell Ther. 2024 Nov.30(11):1100.e1-1100.e11. Pubmedid: 39243817.
- Park W, Chen J, Chou JF, Varghese AM, Yu KH, Wong W, Capanu M, Balachandran V, McIntyre CA, El Dika I, Khalil DN, Harding JJ, Ghalehsari N, McKinnell Z, Chalasani SB, Makarov V, Selenica P, Pei X, Lecomte N, Kelsen DP, Abou-Alfa GK, Robson ME, Zhang L, Berger MF, Schultz N, Chan TA, Powell SN, Reis-Filho JS, Iacobuzio-Donahue CA, Riaz N, O'Reilly EM. Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection. Clin Cancer Res. 2020 Jul.26(13):3239-3247. Pubmedid: 32444418. Pmcid: PMC7380542.
- Mazloom A, Ghalehsari N, Gazivoda V, Nimkar N, Paul S, Gregos P, Rateshwar J, Khan U. Role of Immune Checkpoint Inhibitors in Gastrointestinal Malignancies. J Clin Med. 2020 Aug.9(8). Pubmedid: 32781500. Pmcid: PMC7463795.
- Lee SI, Huang A, Mortazavi B, Li C, Hoffman HA, Garst J, Lu DS, Getachew R, Espinal M, Razaghy M, Ghalehsari N, Paak BH, Ghavam AA, Afridi M, Ostowari A, Ghasemzadeh H, Lu DC, Sarrafzadeh M. Quantitative assessment of hand motor function in cervical spinal disorder patients using target tracking tests. J Rehabil Res Dev. 2016 Dec.53(6):1007-1022. Pubmedid: 28475202.
- Hoffman H, Lee SI, Garst JH, Lu DS, Li CH, Nagasawa DT, Ghalehsari N, Jahanforouz N, Razaghy M, Espinal M, Ghavamrezaii A, Paak BH, Wu I, Sarrafzadeh M, Lu DC. Use of multivariate linear regression and support vector regression to predict functional outcome after surgery for cervical spondylotic myelopathy. J Clin Neurosci. 2015 Sep.22(9):1444-1449. Pubmedid: 26115898. Pmcid: PMC4842312.
- Getachew R, Lee SI, Kimball JA, Yew AY, Lu DS, Li CH, Garst JH, Ghalehsari N, Paak BH, Razaghy M, Espinal M, Ostowari A, Ghavamrezaii AA, Pourtaheri S, Wu I, Sarrafzadeh M, Lu DC. Utilization of a novel digital measurement tool for quantitative assessment of upper extremity motor dexterity: a controlled pilot study. J Neuroeng Rehabil. 2014 Aug.11:121. Pubmedid: 25117936. Pmcid: PMC4138400.
-
Patient Comments
0 patients rated this provider
The Provider Rating is an average of all responses to specific care provider-related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Responses are measured on a scale of 1 to 5 with 5 being the best score.
Patients that are treated in outpatient or hospital environments may receive different surveys, and the volume of responses will vary by question.
Learn more about our patient satisfaction surveyComments
Comments are gathered from specific care provider-related questions from our Patient Satisfaction Survey . The comments are submitted by patients and reflect their views and opinions. Patients are de-identified for confidentiality and patient privacy.
Learn more about our patient comments
We post both positive and negative comments from the surveys. We do not post comments that are libelous, slanderous, profane, irrelevant or otherwise inappropriate or may risk the privacy of our patients. A “[…]” in the comments below indicates de-identified patient information or comments that are unrelated to the patient’s experience with the visit to the provider, such as comments related to another provider, about the survey itself, or otherwise completely off-topic.
Provider Ratings and comments are gathered from our nationally-recognized Press Ganey Patient Satisfaction Survey. If a provider does not have ratings or comments listed it can be for several reasons, including:
Learn more about our patient satisfaction survey, ratings and comments